Synthesis and antiprotozoal activity of furanchalcone-quinoline, furanchalcone-chromone and furanchalcone-imidazole hybrids

We report herein the synthesis and biological activities (cytotoxicity, leishmanicidal and trypanocidal) of several furanchalcone quinoline, furanchalcone-chromone and furanchalcone-imidazole hybrids. The synthesized compounds were evaluated against amastigotes forms of L. (V) panamensis, which is t...

Full description

Autores:
Vélez Bernal, Iván Darío
Robledo Restrepo, Sara María
Cardona Galeano, Wilson
Carda Usó, Miguel
Muñoz Úsuga, July Andrea
Otero Tejada, Elver Luis
Coa Acuña, Juan Carlos
García Carvajal, Elisa
Tipo de recurso:
Article of investigation
Fecha de publicación:
2017
Institución:
Universidad de Antioquia
Repositorio:
Repositorio UdeA
Idioma:
eng
OAI Identifier:
oai:bibliotecadigital.udea.edu.co:10495/47252
Acceso en línea:
https://hdl.handle.net/10495/47252
Palabra clave:
Leishmaniasis
Enfermedad de Chagas
Chagas Disease
Antiprotozoarios
Antiprotozoal Agents
Cromonas
Chromones
Quimera
Chimera
Citotoxicidad
Cytotoxicity
http://aims.fao.org/aos/agrovoc/c_34251
https://id.nlm.nih.gov/mesh/D007896
https://id.nlm.nih.gov/mesh/D014355
https://id.nlm.nih.gov/mesh/D000981
https://id.nlm.nih.gov/mesh/D002867
https://id.nlm.nih.gov/mesh/D002678
ODS 3: Salud y bienestar. Garantizar una vida sana y promover el bienestar de todos a todas las edades
Rights
openAccess
License
http://creativecommons.org/licenses/by/4.0/
Description
Summary:We report herein the synthesis and biological activities (cytotoxicity, leishmanicidal and trypanocidal) of several furanchalcone quinoline, furanchalcone-chromone and furanchalcone-imidazole hybrids. The synthesized compounds were evaluated against amastigotes forms of L. (V) panamensis, which is the most prevalent Leishmania species in Colombia and against Trypanosoma cruzi, which is the major pathogenic species to humans. Cytotoxicity was evaluated against human U-937 macrophages. Compounds (6e, 8a-8f, 11b and 11c) were active against both L. (V) panamensis and T. cruzi with EC50 values lower than 25 μg/mL, with 8e and 8f being the most active compounds with an EC50 of 0.39 + 0.06 μg/mL (0.78 µM) and 1.15 + 0.23 μg/mL (2.16 µM) against L. (V) panamensis, respectively, and 0.33 + 0.02 μg/mL (0.66 µM) and 0.39 + 0.02 μg/mL (0.72 µM) against T. cruzi, respectively. All hybrid compounds showed better activity than the anti-leishmanial drug meglumine antimoniate. Compounds 20 and 23 showed higher activities than benznidazole, the current anti-trypanosomal drug. Although these compounds showed toxicity for mammalian U-937 cells, they still have the potential to be considered as candidates for antileishmanial or trypanocydal drug development. There is not a clear relationship between the antiprotozoal activity and the length of the alkyl linker. However, we obtained higher bioactivity when the alkyl linker has nine and twelve carbon atoms. Furanchalcone-imidazole hybrids were the most active of all compounds, showing that the imidazole salt moiety is important for their biological actions.